Showing results (41-50 of 447) with videos related to
Sort By:
Pageof 45
International Journal of Oncology|October 22, 2014
Prognostic significance and therapeutic implications of peroxisome proliferator-activated receptor γ overexpression in human pancreatic carcinomaYan Zhang, Hui-Yan Luo, Guang-Lin Liu, et al.Molecular Cancer|December 16, 2021
The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3pDong-Liang Chen, Hui Sheng, Dong-Sheng Zhang, et al.Journal of Thoracic Disease|April 30, 2015
Impact of body mass index on survival of esophageal squamous carcinoma patients in southern ChinaChao Ren, Xiu-Yu Cai, Miao-Zhen Qiu, et al.Cancer Research|February 8, 2005
Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxiaRui-Hua Xu, Helene Pelicano, Yan Zhou, et al.Journal of Translational Medicine|March 19, 2013
Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in ChinaMiao-zhen Qiu, Mu-yan Cai, Dong-sheng Zhang, et al.Journal of Materials Chemistry. B|April 8, 2020
Enzymatically synthesized poly(amino-co-ester) polyplexes for systemic delivery of pcDNA-miRNA-214 to suppress colorectal cancer liver metastasisHui-Yan Luo, Zhe Yang, Wei Wei, et al.Journal of Translational Medicine|December 14, 2020
PD-L1 expression in liver metastasis: its clinical significance and discordance with primary tumor in colorectal cancerXiao-Li Wei, Xuan Luo, Hui Sheng, et al.Medical Oncology (Northwood, London, England)|January 14, 2015
Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatmentLong Bai, Dong-Sheng Zhang, Wen-Jing Wu, et al.Cancer Research|November 20, 2016
CBX4 Suppresses Metastasis via Recruitment of HDAC3 to the Runx2 Promoter in Colorectal CarcinomaXin Wang, Liping Li, Yuanzhong Wu, et al.Journal for Immunotherapy of Cancer|April 2, 2021
Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trialsZi-Xian Wang, Hao-Xiang Wu, Li Xie, et al.Pageof 45